Rheumatologists and RA experts, Marc Cohen, MD, and Jonathan Kay, MD, have selected research presentations that address practical issues across the RA management spectrum, including early management; biomarkers; new data on biologics, conventional DMARDs, and biosimilars; as well as safety.